(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 10.93% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Atricure's revenue in 2026 is $569,622,000.On average, 12 Wall Street analysts forecast ATRC's revenue for 2026 to be $31,452,664,232, with the lowest ATRC revenue forecast at $30,138,787,858, and the highest ATRC revenue forecast at $32,526,451,698. On average, 12 Wall Street analysts forecast ATRC's revenue for 2027 to be $35,264,075,641, with the lowest ATRC revenue forecast at $33,508,679,835, and the highest ATRC revenue forecast at $36,617,119,062.
In 2028, ATRC is forecast to generate $39,675,200,657 in revenue, with the lowest revenue forecast at $37,700,571,124 and the highest revenue forecast at $41,184,403,600.